產(chǎn)品詳情
簡單介紹：
Anti-APOA1抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-APOA1抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-APOA1
Cat. Number:
Anti-APOA1抗體XY-0849R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene encodesAnti-APOA1抗體 apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The protein promotes cholesterol efflux from tissues to the liver for excretion, and it is a cofactor for lecithin cholesterolacyltransferase (LCAT) which is responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. [provided by RefSeq, Jul 2008]
Also known as:
AI BP; AIBP; Anti-APOA1抗體ApoA I binding protein; Apolipoprotein A I; Apolipoprotein A 1; Apo AI; ApoA I; APOA1; APOA1/APOC3 fusion gene; Apo A1; Apo-A1; Apolipoprotein A I precursor; Apolipoprotein A I binding protein; Apolipoprotein AI; Apolipoprotein of high density lipoprotein; ApolipoproteinAI; Brp14; Ltw1; Lvtw1; MGC117399; MGC119143; MGC119144; MGC119145; NAD(P)H hydrate epimerase; NAD(P)HX epimerase; YjeF N terminal domain containing protein 1; yjeF_N1; YJEFN1; APOA1_HUMAN; Sep1; Sep2.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Chicken, Pig, Cow, .
●
Immunogen: KLH conjugated syntheticAnti-APOA1抗體 peptide derived from human APOA1.
●
Predicted Molecular Weight: 28kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be Anti-APOA1抗體determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be Anti-APOA1抗體determined by the end user.
xy-12566R ACAA1乙酰輔酶A酰基轉(zhuǎn)移酶1抗體
xy-12581R phospho-beta Actin (Tyr53)磷酸化β-肌動(dòng)蛋白抗體
xy-12978R phospho-beta 2 Adrenergic Receptor (Ser346)磷酸化腎上腺素能受體β2/β2-AR 抗體
xy-12979R phospho-beta 2 Adrenergic Receptor (Ser355 + Ser356)磷酸化腎上腺素能受體β2/β2-AR抗體
xy-10130R APOD載脂蛋白D抗體
xy-2586R ASIC1/BNaC2/ASIC1A酸敏感離子通道1抗體
xy-2168R ADAR1 (C-terminus)雙鏈RNA腺苷酸脫氨基酶抗體（C端）
xy-3696R AF10髓系、**、混合系白血病易位基因10抗體
xy-3681R ADCY1腺苷酸環(huán)化酶1抗體
xy-3680R APC腺瘤樣息肉抗體
xy-5023R AGPAT1溶血磷脂酰基轉(zhuǎn)移酶抗體
xy-9098R ANKS3錨蛋白重復(fù)及SAM結(jié)構(gòu)域蛋白3抗體
xy-3047R phospho-ALK (Tyr1586)磷酸化間變型**瘤激酶抗體
xy-5018R ACADVL酰基輔酶A脫氫酶很長鏈抗體
xy-7735R AMSH信號轉(zhuǎn)導(dǎo)銜接結(jié)合蛋白抗體
xy-7736R ASB3錨蛋白重復(fù)序列-細(xì)胞因子信號抑制物盒蛋白家族3抗體
xy-2750R Aurora C有絲分裂激酶B抗體
xy-3045R Phospho-Ack1 (Tyr284)磷酸化Ack1抗體
xy-3046R Phospho-Ack1 (Tyr326)磷酸化Ack1抗體
xy-3048R Phospho-beta-Arrestin 1 (Ser412)磷酸化β抑制蛋白1抗體
xy-3050R Phospho-Aurora A (Thr288)磷酸化有絲分裂激酶A抗體
xy-3003R phospho-APS(Ser598)磷酸化APS抗體
xy-2749R Aurora A有絲分裂激酶A抗體
xy-5986R AIM2干擾素誘導(dǎo)蛋白AIM2抗體
